SLC16A7 and Alzheimer disease: Application of a MCT2 inhibitor, 4-CIN, to prevent lactate uptake in hippocampal neurons increased glutamate-induced neuronal discharge abnormalities in the CA1 region of the hippocampus as is frequently seen in AD [100].